Abstract:Microglia, the macrophages of the brain, are vital for brain homeostasis and have been implicated in a broad range of brain disorders. Neuroinflammation has gained traction as a possible therapeutic target for neurodegeneration, however, the precise function of microglia in specific neurodegenerative disorders is an ongoing area of research. Genetic studies offer valuable insights into understanding causality, rather than merely observing a correlation. Genome-wide association studies (GWAS) have identified many genetic loci that are linked to susceptibility to neurodegenerative disorders. (Post)-GWAS studies have determined that microglia likely play an important role in the development of Alzheimer's disease (AD) and Parkinson's disease (PD). The process of understanding how individual GWAS risk loci affect microglia function and mediate susceptibility is complex. A rapidly growing number of publications with genomic datasets and computational tools have formulated new hypotheses that guide the biological interpretation of AD and PD genetic risk. In this review, we discuss the key concepts and challenges in the post-GWAS interpretation of AD and PD GWAS risk alleles. Post-GWAS challenges include the identification of target cell (sub)type(s), causal variants, and target genes. Crucially, the prediction of GWAS-identified disease-risk cell types, variants and genes require validation and functional testing to understand the biological consequences within the pathology of the disorders. Many AD and PD risk genes are highly pleiotropic and perform multiple important functions that might not be equally relevant for the mechanisms by which GWAS risk alleles exert their effect(s). Ultimately, many GWAS risk alleles exert their effect by changing microglia function, thereby altering the pathophysiology of these disorders, and hence, we believe that modelling this context is crucial for a deepened understanding of these disorders.

Microglia: roles and genetic risk in Parkinson's disease

Microglial Activation Induced by Neurodegeneration

Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease

Parkinson’s disease risk enhancers in microglia

Microglia Mediated Neuroinflammation in Parkinson's Disease

Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets

MicroRNAs Play a Role in Parkinson's Disease by Regulating Microglia Function: From Pathogenetic Involvement to Therapeutic Potential

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson's Disease

Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease

Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets

Microglia in Neurodegenerative Diseases

Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Role of G Protein-Coupled Receptors in Microglial Activation: Implication in Parkinson’s Disease

Genetic risk for neurodegenerative conditions is linked to disease-specific microglial pathways

Heritability Enrichment Implicates Microglia in Parkinson's Disease Pathogenesis

Interpretation of Neurodegenerative GWAS Risk Alleles in Microglia and their Interplay with Other Cell Types

Neuroinflammation, Oxidative Stress and the Pathogenesis of Parkinson's Disease

Neuroinflammation in Parkinson's disease: focus on the relationship between miRNAs and microglia

The Role of Abnormally Activated Microglia in the Pathogenesis of Parkinson's Disease and Its Potential Clinical Application

Role of Α-Synuclein in Microglia: Autophagy and Phagocytosis Balance Neuroinflammation in Parkinson’s Disease

Microglial Dysfunction in Brain Aging and Neurodegeneration